[1] 刘月驹,秦士吉,李升,等.膝关节失衡综合征在骨科临床中的应用[J].河北医科大学学报,2015,36(5):598.
[2] 王斌,邢丹,董圣杰,等.中国膝骨关节炎流行病学和疾病负担的系统评价[J].中国循证医学杂志,2018,18(2):134-142.
[3] SINGH A K, KALAIVANI M, KRISHNAN A, et al. Prevalence of osteoarthritis of knee among elderly persons in urban slums using american college of rheumatology (ACR) criteria. J Clin Diagn Res. 2014; 8(9):9-11.
[4] MILLER RH. Joint loading in runners does not initiate knee osteoarthritis. Exerc Sport Sci Rev. 2017;45(2):87-95.
[5] MICHELLE L. Knee osteoarthritis: a primer. Perm J. 2017;21:16-183.
[6] SAMUELS J, KRASNOKUTSKY S, ABRAMSON SB. Osteoarthritis:a tale of three tissues. Bull Nyu Hosp Jt Dis. 2008;66(3):244-250.
[7] HWANG HS, KIM HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci. 2015;16(11):26035-26054.
[8] TEMPLE-WONG MM, REN S, QUACH P, et al. Hyaluronan concentration and size distribution in human knee synovial fluid: variations with age and cartilage degeneration. Arthritis Res Ther. 2016;18(1):1-8.
[9] LI G, YIN J, GAO J, et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013;15(6): 223.
[10] 田胜兰,王国延,杨扬.人甲壳质酶蛋白40通过PI3K/Akt信号通路调控膝骨性关节炎兔软骨细胞的凋亡[J].中国组织工程研究, 2020,24(32):5108-5113.
[11] HUSSAIN SM, NEILLY DW, BALIGA S, et al. Knee osteoarthritis: a review of management options. Scott Med J. 2016;61(1):7-16.
[12] PRIMORAC D, MOLNAR V, ROD E, et al. Knee osteoarthritis: a review of pathogenesis and state-of-the-art non-operative therapeutic considerations. Genes (Basel). 2020;11(8):854.
[13] SHI GX, TU JF, WANG TQ, et al. Effect of electro-acupuncture (EA) and manual acupuncture (MA) on markers of inflammation in knee osteoarthritis. J Pain Res. 2020;13:2171-2179.
[14] 刘搏宇,李宏宇,席立成,等.不同剂量体外冲击波治疗膝骨性关节炎近期疗效比较[J].中国矫形外科杂志,2020,28(11):908-912.
[15] DESANDO G, BARTOLOTTI I, CAVALLO C, et al. Short-term homing of hyaluronan-primed cells: therapeutic implications for osteoarthritis treatment. Tissue Eng Part C Methods. 2018;24(2):121-133.
[16] WANG Z, ZHAI C, FEI H, et al. Intraarticular injection autologous platelet‐rich plasma and bone marrow concentrate in a goat osteoarthritis model. J Orthop Res. 2018;36(8):2140-2146.
[17] KOCH M, HAMMER S, FUELLERER J, et al. Bone marrow aspirate concentrate for the treatment of avascular meniscus tears in a one-step procedure-evaluation of an in vivo model. Int J Mol Sci. 2019; 20(5):1120.
[18] SHAPIRO SA, KAZMERCHAK SE, HECKMAN MG, et al. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2017;45(1):82-90.
[19] Gobbi A, Scotti C, Karnatzikos G, et al. One-step surgery with multipotent stem cells and Hyaluronan-based scaffold for the treatment of full-thickness chondral defects of the knee in patients older than 45 years. Knee Surg Sports Traumatol Arthrosc. 2017;25(8):2494-2501.
[20] THEMISTOCLEOUS GS, CHLOROS GD, KYRANTZOULIS IM, et al. Effectiveness of a single intra-articular bone marrow aspirate concentrate (BMAC) injection in patients with grade 3 and 4 knee osteoarthritis. Heliyon. 2018;4(10):e00871.
[21] SHAW B, DARROW M, DERIAN A. Short-term outcomes in treatment of knee osteoarthritis with 4 bone marrow concentrate injections. Clin Med Insights Arthritis Musculoskelet Disord. 2018;11: 1179544118781080.
[22] CENTENO CJ, AL-SAYEGH H, BASHIR J, et al. A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis. BMC Musculoskelet Disord. 2015;16:258.
[23] KIM JD, LEE GW, JUNG GH, et al. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol. 2014;24(8):1505-1511.
[24] CENTENO CJ, PITTS JA, AL-SAYEGH H, et al. Efficacy and safety of bone marrow concentrate for osteoarthritis of the hip: treatment registry results for 196 patients. J Stem Cell Res Ther. 2014;4(242):2.
[25] CENTENO C, PITTS J, AL-SAYEGH H, et al. Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014;2014:370621.
[26] CENTENO C J, AL-SAYEGH H, FREEMAN MD, et al. A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. Int Orthop. 2016;40(8):1755-1765.
[27] SALTZMAN BM, KUHNS BD, WEBER AE, et al. Stem cells in orthopedics: a comprehensive guide for the general orthopedist. Am J Orthop. 2016;45(5):280-326.
[28] CAPLAN AI. Review: mesenchymal stem cells:cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005;11(7-8):1198-1211.
[29] CHEN FH, TUAN RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10(5):223-223.
[30] 高祎,杨柳.骨髓间充质干细胞移植应用于骨科的研究进展[J].中华骨科杂志,2017,37(2):121-128.
[31] DE LUCA P, KOUROUPIS D, VIGANÒ M, et al. Human diseased articular cartilage contains a mesenchymal stem cell-like population of chondroprogenitors with strong immunomodulatory responses. J Clin Med. 2019;8(4):423.
[32] LAMO-ESPINOSA JM, GONZALO M, BLANCO JF, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II). J Transl Med. 2018;16(1):213.
[33] CENTENO CJ, BUSSE D, KISIDAY J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells, platelet lysate and dexamethasone. Pain Physician. 2008;9(3):246-251.
[34] OROZCO L, MUNAR A, SOLER R, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells:a pilot study. Transplantation. 2013;95(12):1535-1541.
[35] IMAM M A, HOLTON J, HORRIAT S, et al. A systematic review of the concept and clinical applications of bone marrow aspirate concentrate in tendon pathology. Sicot J. 2017;3:58.
[36] FILARDO G, PERDISA F, ROFFI A, et al. Stem cells in articular cartilage regeneration. J Orthop Surg Res. 2016;11(1):1-15.
[37] CASSANO JM, KENNEDY JG, ROSS KA, et al. Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc. 2018;26(1):333-342.
[38] MIYAZAWA K, SHINOZAK M I, HARA T, et al. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells. 2010;7(12):1191-1204.
[39] MARIANI E, PULSATELLI L, FACCHINI A. Signaling pathways in cartilage repair. Int J Mol Sci. 2014;15(5):8667-8698.
[40] Chen S, Liu S, Ma K, et al. TGF-β signaling in intervertebral disc health and disease. Osteoarthritis Cartilage. 2019;27(8):1109-1117.
[41] 张立智,卫禛,张世民.转化生长因子β信号在骨关节炎中的作用[J].中华骨与关节外科杂志,2019,12(9):727-732.
[42] KIM JM, LIN C, STAVRE Z, et al. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073.
[43] 雷文龙,施斌.血小板衍生生长因子BB在口腔种植领域中的作用[J].国际口腔医学杂志,2014,41(2);199-203.
[44] YANG F, LI WB, QU YW, et al. Bone marrow mesenchymal stem cells induce M2 microglia polarization through PDGF-AA/MANF signaling. World J Stem Cells. 2020;12(7):633-658.
[45] 刘慧,陈慧鸿,廖红兵.破骨细胞衍生的偶联因子鞘氨醇-1-磷酸及血小板衍生生长因子BB对成骨细胞的调节作用[J].中国组织工程研究,2019,23(23):3739-3745.
[46] SETIAWAN IGNY, SUYASA IK, ASTAWA P, et al. Recombinant platelet derived growth factor-BB and hyaluronic acid effect in rat osteoarthritis models. J Orthop. 2019;16(3):230-233.
[47] SUYASA IK, LESTARI AAW, SETIAWAN IGNY. Recombinant platelet-derived growth factor-BB and hyaluronic acid stimulates knee cartilage regeneration by forming higher chondrocytes count and lower YKL-40 level in rats model. J Clin Orthop Trauma. 2020; 11(Suppl 1):S76-S79.
[48] FORTIER LA, BARKER JU, STRAUSS EJ, et al. The role of growth factors in cartilage repair. Clin Orthop Relat Res. 2011;469(10):2706-2715.
[49] YANG YH, ARD MB, HALPER JT, et al. Type i collagen-based fibrous capsule enhances integration of tissue-engineered cartilage with native articular cartilage. Ann Biomed Eng. 2014;42(4):716.
[50] CUCCHIARINI M, MADRY H. Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo. Gene Ther. 2014;21(9):811-819.
[51] EKENSTEDT KJ, SONNTAG WE, LOESER RF, et al. Effects of chronic growth hormone and insulin-like growth factor 1 deficiency on osteoarthritis severity in rat knee joints. Arthritis Rheum. 2006;54(12): 3850-3858.
[52] GOODRICH LR, HIDAKA C, ROBBINS PD, et al. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br. 2007;89(5):672-685.
[53] 李嘉怡,刘双全,邵瑞,等.成纤维细胞生长因子18对骨和软骨发育[J].中南医学科学杂志,2019,47(1):102-105, 112.
[54] ELLMAN MB, AN H S, MUDDASANI P, et al. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene. 2008;420(1):82-89.
[55] CINQUE L, FORRESTER A, BARTOLOMEO R, et al. FGF signalling regulates bone growth through autophagy. Nature. 2015;528(7581):272-275.
[56] MORI Y, SAITO T, CHANG SH, et al. Identification of fibroblast growth factor-18 as a molecule to protect adult articular cartilage by gene expression profiling. J Biol Chem. 2014;289(14):10192-10200.
[57] REKER D, SIEBUHR AS, THUDIUM CS, et al. Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo. Sci Rep. 2020;10(1):6011.
[58] FU HD, WANG HR, LI DH. BMP-7 accelerates the differentiation of rabbit mesenchymal stem cells into cartilage through the Wnt/β-catenin pathway. Exp Ther Med. 2017;14(6):5424-5428.
[59] MALYSHEVA KV, SPASYUK IM, PAVLENKO OK, et al. Generation of optimized preparations of bone morphogenetic proteins for bone regeneration. Ukr Biochem J. 2016;88(6):87-97.
[60] 赵晋,闫振宇,张立智.骨性关节炎软骨和软骨下骨之间信号通路[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(2):193-198.
|